Common SNPs/haplotypes in IL18R1 and IL18 genes are associated with variations in humoral immunity to smallpox vaccination in Caucasians and African Americans

Journal of Infectious Diseases

Volumn 204, Issue 3, 2011, Pages 433-441

  Haralambieva, Iana H ^a   Ovsyannikova, Inna G ^a   Dhiman, Neelam ^a   Kennedy, Richard B ^a   O'Byrne, Megan ^a   Pankratz, V Shane ^a   Jacobson, Robert M ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; SMALLPOX VACCINE;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMORAL IMMUNITY; IL18 GENE; IL18D1 GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE DRUG DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; SMALLPOX;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ANTIBODIES, VIRAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HAPLOTYPES; HUMANS; IMMUNITY, HUMORAL; INTERLEUKIN-18; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; LINEAR MODELS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SMALLPOX VACCINE; VACCINATION;

EID: 79960142368     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir268     Document Type: Article

References (50)

1. Poland GA, Ovsyannikova IG, Jacobson RM, Smith DI. Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics. Clin Pharmacol Ther 2007; 82:653-64. (Pubitemid 350114830)
2. Ovsyannikova IG, Jacobson RM, Dhiman N, Vierkant RA, Pankratz VS, Poland GA. Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine. Pediatrics 2008; 121:1091-9.
3. Dhiman N, Ovsyannikova IG, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA. Associations between cytokine/cytokine receptor SNPs and humoral immunity to measles, mumps and rubella in a Somali population. Tissue Antigens 2008; 72:211-20.
4. Dhiman N, Haralambieva IH, Kennedy RB, et al. SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine. Immunogenetics 2010; 62:197-210.
5. Dhiman N, Ovsyannikova IG, Cunningham JM, et al. Associations between measles vaccine immunity and single nucleotide polymorphisms in cytokine and cytokine receptor genes. J Infect Dis 2007; 195:21-9. (Pubitemid 44958223)
6. Poland GA, Ovsyannikova IG, Jacobson RM. Immunogenetics of seasonal influenza vaccine response. Vaccine 2008; 26(Suppl 4):D35-40.
7. Kennedy RB, Ovsyannikova IG, Jacobson RM, Poland GA. The immunology of smallpox vaccines. Curr Opin Immunol 2009; 21:314-20.
8. Nalca A, Rimoin AW, Bavari S, Whitehouse CA. Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clin Infect Dis 2005; 41:1765-71. (Pubitemid 41759863)
9. Thio CL, Thomas DL, Goedert JJ, et al. Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis 2001; 184:16-21. (Pubitemid 32568495)
10. de la C Sierra B, Kouri G, Guzman MG. Race: a risk factor for dengue hemorrhagic fever. Arch Virol 2007; 152:533-42. (Pubitemid 46363592)
11. Kennedy R, Ovsyannikova IG, Pankratz VS, et al. Gender effects on humoral immune response to smallpox vaccine. Vaccine 2008; 27:3319-23.
12. Dominguez A, Plans P, Costa J, et al. Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study. Eur J Clin Microbiol Infect Dis 2006; 25:310-7.
13. Klein NP, Holmes TH, Sharp MA, et al. Variability and gender differences in memory T cell immunity to varicella-zoster virus in healthy adults. Vaccine 2006; 24:5913-8. (Pubitemid 44088668)
14. Cook IF. Sexual dimorphism of humoral immunity with human vaccines. Vaccine 2008; 26:3551-5.
15. Martin AM, Athanasiadis G, Greshock JD, et al. Population frequencies of single nucleotide polymorphisms (SNPs) in immuno-modulatory genes. Hum Hered 2003; 55:171-8. (Pubitemid 37323454)
16. Poland GA, Ovsyannikova IG, Jacobson RM. Application of pharmacogenomics to vaccines. Pharmacogenomics 2009; 10:837-52.
17. Stanley SL Jr, Frey SE, Taillon-Miller P, et al. The immunogenetics of smallpox vaccination. J Infect Dis 2007; 196:212-9. (Pubitemid 47047460)
18. Reif DM, McKinney BA, Motsinger AA, et al. Genetic basis for adverse events after smallpox vaccination. J Infect Dis 2008; 198:1-7.
19. Davis NA, Crowe JE Jr, Pajewski NM, McKinney BA. Surfing a genetic association interaction network to identify modulators of antibody response to smallpox vaccine. Genes Immun 2010; 11:630-6.
20. Manischewitz J, King LR, Bleckwenn NA, et al. Development of a novel vaccinia-neutralization assay based on reporter-gene expression. J Infect Dis 2003; 188:440-8. (Pubitemid 36960656)
21. Huber PJ. Robust regression: asymptotics, conjectures and Monte Carlo. Ann Statist 1973; 1:799-821.
22. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004; 74:106-20. (Pubitemid 38085242)
23. Haralambieva IH, Dhiman N, Ovsyannikova IG, et al. 2′-5′- Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine. Hum Immunol 2010; 71:383-91.
24. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genomewide association studies. Nat Genet 2006; 38:904-9. (Pubitemid 44141658)
25. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-5. (Pubitemid 40202029)
26. Storey JD. A direct approach to false discovery rates. J R Statist Soc B 2002; 64:479-98.
27. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003; 100:9440-5. (Pubitemid 37033947)
28. Wang K, Abbott D. A principal components regression approach to multilocus genetic association studies. Genet Epidemiol 2008; 32: 108-18. (Pubitemid 351288028)
29. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70:425-34. (Pubitemid 34112296)
30. Schaid DJ. Evaluating associations of haplotypes with traits. Genet Epidemiol 2004; 27:348-64. (Pubitemid 39602319)
31. Zhernakova A, Festen EM, Franke L, et al. Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. Am J Hum Genet 2008; 82:1202-10.
32. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001; 12:53-72. (Pubitemid 32294587)
33. Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol 2010; 10:89-102.
34. Guo L, Wei G, Zhu J, et al. IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc Natl Acad Sci U S A 2009; 106:13463-8.
35. Tanaka-Kataoka M, Kunikata T, Takayama S, et al. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection. Cytokine 1999; 11:593-9.
36. Wang Y, Chaudhri G, Jackson RJ, Karupiah G. IL-12p40 and IL-18 play pivotal roles in orchestrating the cell-mediated immune response to a poxvirus infection. J Immunol 2009; 183:3324-31.
37. Gherardi MM, Ramirez JC, Esteban M. IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system. J Gen Virol 2003; 84(Pt 8): 1961-72. (Pubitemid 36927225)
38. Reading PC, Smith GL. Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity. J Virol 2003; 77:9960-8. (Pubitemid 37122077)
39. Scherer CA, Magness CL, Steiger KV, et al. Distinct gene expression profiles in peripheral blood mononuclear cells from patients infected with vaccinia virus, yellow fever 17D virus, or upper respiratory infections. Vaccine 2007; 25:6458-73. (Pubitemid 47208589)
40. Azam T, Novick D, Bufler P, et al. Identification of a critical Ig-like domain in IL-18 receptor alpha and characterization of a functional IL-18 receptor complex. J Immunol 2003; 171:6574-80. (Pubitemid 37532088)
41. Reijmerink NE, Postma DS, Bruinenberg M, et al. Association of IL1RL1, IL18R1, and IL18RAP gene cluster polymorphisms with asthma and atopy. J Allergy Clin Immunol 2008; 122:651-4.
42. Reijmerink NE, Postma DS, Koppelman GH. The candidate gene approach in asthma: what happens with the neighbours? Eur J Hum Genet 2010; 18:17-8.
43. Zhu G, Whyte MK, Vestbo J, et al. Interleukin 18 receptor 1 gene polymorphisms are associated with asthma. Eur J Hum Genet 2008; 16:1083-90.
44. Takagawa T, Tamura K, Takeda N, et al. Association between IL-18 gene promoter polymorphisms and inflammatory bowel disease in a Japanese population. Inflamm Bowel Dis 2005; 11:1038-43. (Pubitemid 41682559)
45. Tiret L, Godefroy T, Lubos E, et al. Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 2005; 112:643-50. (Pubitemid 41099042)
46. He M, Cornelis MC, Kraft P, et al. Genome-wide association study identifies variants at the IL18-BCO2 locus associated with interleukin-18 levels. Arterioscler Thromb Vasc Biol 2010; 30:885-90.
47. Harada M, Obara K, Hirota T, et al. A functional polymorphism in IL-18 is associated with severity of bronchial asthma. Am J Respir Crit Care Med 2009; 180:1048-55.
48. Haas SL, Weiss C, Bugert P, et al. Interleukin 18 promoter variants (-137G.C and -607C.A) in patients with chronic hepatitis C: association with treatment response. J Clin Immunol 2009; 29:620-8.
49. An P, Thio CL, Kirk GD, Donfield S, Goedert JJ, Winkler CA. Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance. J Infect Dis 2008; 198:1159-65.
50. Poland GA, Grabenstein JD, Neff JM. The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program. Vaccine 2005; 23:2078-81. (Pubitemid 40341430)